Norman Parathyroid Center, Tampa, FL 33544, USA.
J Am Coll Surg. 2010 Aug;211(2):244-9. doi: 10.1016/j.jamcollsurg.2010.03.040.
Although localizing studies are well-known predictors of which patients are candidates for unilateral versus bilateral parathyroid exploration, there are a number of other factors that have positive or negative influence preoperatively and intraoperatively.
A prospective study was conducted during 20 months on 3,000 consecutive patients undergoing surgery for primary hyperparathyroidism to determine which factors caused the surgeons to explore bilaterally or, in contrast, influenced a unilateral approach. Seventeen preoperative and 5 intraoperative objective points were documented on all patients to see how decisions were made.
Parathyroidectomy was unilateral in 32% and bilateral in 68%. Preoperative factors that had a positive predictive value in dictating a unilateral approach were (in decreasing frequency): positive sestamibi, previous parathyroid/thyroid surgery, age older than 80 years, anticoagulation medications, morbid obesity, and presence of large goiter (all p < 0.001). Preoperative parameters dictating a bilateral approach included negative sestamibi, more than one focus on sestamibi, contralateral thyroid disease, family history, lithium use, history of radiation, MEN, age younger than 20 years, and pregnancy (all p < 0.001). Intraoperative parameters influencing conversion of unilateral to bilateral were false-positive sestamibi, hormone measures not meeting sufficient levels, abnormal ipsilateral gland, and contralateral thyroid pathology identified (all p < 0.001). Factors that had no effect were gender, degree of calcium, and/or parathyroid hormone elevation, and age between 20 and 80 years. Cure rates were 99.9% for bilateral and 99.0% for unilateral (p = 0.057).
High-volume surgeons use a number of identifiable objective factors to determine the best candidates for unilateral versus bilateral parathyroid exploration. Localizing studies such as sestamibi scans ultimately play a minor role in determining how many parathyroid glands are evaluated.
尽管局部定位研究是预测哪些患者适合单侧与双侧甲状旁腺探查的重要指标,但术前和术中还有许多其他因素会产生积极或消极的影响。
在 20 个月期间,对 3000 例因原发性甲状旁腺功能亢进症而行手术治疗的连续患者进行了前瞻性研究,以确定哪些因素导致外科医生选择双侧探查,或者相反,影响单侧探查。对所有患者记录了 17 项术前和 5 项术中客观指标,以了解决策的依据。
甲状旁腺切除术的侧别分别为 32%和 68%。术前因素中,阳性 99mTc-甲氧基异丁基异腈( sestamibi)、既往甲状旁腺/甲状腺手术、年龄大于 80 岁、抗凝药物、病态肥胖和大甲状腺肿的存在具有单侧探查的阳性预测值(均 p < 0.001)。提示双侧探查的术前参数包括阴性 sestamibi、sestamibi 上有多个焦点、对侧甲状腺疾病、家族史、锂的使用、放疗史、多发性内分泌腺瘤病(MEN)、年龄小于 20 岁和妊娠(均 p < 0.001)。影响单侧转为双侧的术中参数包括假阳性 sestamibi、激素水平未达到足够水平、同侧腺体异常和对侧甲状腺病理改变(均 p < 0.001)。无影响的因素是性别、血钙和(或)甲状旁腺激素升高程度以及 20-80 岁的年龄。双侧和单侧的治愈率分别为 99.9%和 99.0%(p = 0.057)。
高容量外科医生使用一些可识别的客观因素来确定单侧与双侧甲状旁腺探查的最佳患者。像 sestamibi 扫描这样的定位研究最终在确定需要评估的甲状旁腺数量方面的作用较小。